Video Latest - ecancer

PARP inhibitors and prostate cancer: A new era of precision medicine

Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain

4 Aug 2020

Atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers

Dr Mark Yarchoan - John Hopkins Medicine, Baltimore, USA

30 Jul 2020

New strategy for ecancermedicalscience: supporting publications in under-resourced settings

Prof Richard Sullivan (Chair of Trustees, ecancer Global Foundation) and Dr Eduardo Cazap (Editor in chief, ecancer, President, SLACOM)

29 Jul 2020

CaRE2 Cancer Research Link© : Introducing the CaRE2 Health Equity Center

Prof Folakemi Odedina, Dr John Carpten and Dr Renee Reams

29 Jul 2020

Oncology pharmacist perspective on PARP inhibitors for castration-resistant prostate cancer

Dr Grace Martin - The University of Kansas Cancer Center, Kansas City, USA

27 Jul 2020

The role of PARP-2 in inhibiting prostate cancer

Prof Li Jia - Harvard Medical School, Boston, USA

27 Jul 2020

OncoAlert and ecancer weekly roundup for July 19-25 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

27 Jul 2020

Epidemiology of gastric cancer

Prof. Carlo La Vecchia - University of Milan, Italy

22 Jul 2020

Pathology of diffuse gastric cancer with CDH1 mutation

Prof. Fàtima Carneiro - University of Porto, Portugal

22 Jul 2020

Prophylactic gastrectomy in CDH1 mutation

Prof. Franco Roviello - University of Siena, Italy

22 Jul 2020

Future perspective of CDH1 mutation in gastric and breast cancers

Dr. Giovanni Corso - University of Milan, Italy, Meeting president

22 Jul 2020

The European Cancer Prevention Organization

Prof. Jaak Janssens - Hasselt, Belgium

22 Jul 2020

Video